Conversion the Intestinal Smooth Muscle Cells of Hirschsprung’s Disease into Enteric Neurons-like Cells by Small Molecule Compounds
Topic overview
This research explores converting intestinal smooth muscle cells from Hirschsprung's disease patients into enteric neuron-like cells using small molecule compounds, addressing the challenge of obtaining sufficient cells for ENS transplantation therapy. The approach offers a potential non-genetic editing solution for treating this congenital disorder that affects gut function in approximately 1 in 5,000 newborns.
Key takeaways
- The enteric nervous system (ENS) is a complex neuronal network in the gut wall essential for gastrointestinal function regulation.
- Hirschsprung's disease results from ENS defects and affects approximately 1 in 5,000 live births worldwide.
- ENS transplantation shows promise as a treatment approach but faces challenges in sourcing adequate non-gene edited ENS tissue.
- Small molecule compounds may enable conversion of intestinal smooth muscle cells into enteric neuron-like cells for therapeutic use.
Keywords
Hashtags
Full article text
Full article text not available for this entry
How to cite: GlobalCastMD. Conversion the Intestinal Smooth Muscle Cells of Hirschsprung’s Disease into Enteric Neurons-like Cells by Small Molecule Compounds. GlobalCastMD Medical Library. 2025-12-30. https://library.globalcastmd.com/article/11353
Comments